{
    "clinical_study": {
        "@rank": "109393", 
        "brief_summary": {
            "textblock": "A prospective, multi-center study to evaluate the neuro-embolic consequences of\n      Transcatheter Aortic Valve Replacement (TAVR)"
        }, 
        "brief_title": "A Study to Evaluate the Neuro-embolic Consequences of TAVR", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Valve Stenosis", 
        "condition_browse": {
            "mesh_term": "Aortic Valve Stenosis"
        }, 
        "detailed_description": {
            "textblock": "Prospective, multi-center study enrolling a minimum of 20 up to a maximum of 80 patients at\n      up to six investigational sites in the United States and European Union. Patients meeting\n      eligibility criteria for TAVR will be enrolled to undergo diffusion-weighted  MRI brain\n      imaging pre-procedure (optional) and post-procedure and neuropsychological testing pre- and\n      post-procedure, and at 30 days of follow-up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must be \u226518 years of age.\n\n          -  Patient meets indications for TAVR procedure.\n\n          -  The patient is willing to comply with protocol-specified follow-up evaluations.\n\n          -  The patient, or legally authorized representative, has been informed of the nature of\n             the study, agrees to its provisions and has provided written informed consent,\n             approved by the appropriate Institutional Review Board (IRB) or Ethics Committee\n             (EC).\n\n        Exclusion Criteria:\n\n          -  Patients undergoing TAVR via the trans-axillary, subclavian, or direct aortic route\n\n          -  Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 year\n             following index procedure. Female subjects of child-bearing potential must have a\n             negative pregnancy test done within 7 days prior to index procedure per site standard\n             test.\n\n          -  Patients with known diagnosis of acute myocardial infarction (AMI) within 72 hours\n             preceding the index procedure (according to definition) or AMI >72 hours preceding\n             the index procedure, in whom creatine kinase and creatine kinase have not returned to\n             within normal limits at the time of procedure.\n\n          -  Patients who are currently experiencing clinical symptoms consistent with new onset\n             AMI, such as nitrate-unresponsive prolonged chest pain.\n\n          -  Patients with impaired renal function (estimated Glomerular Filtration Rate\n             [Estimated Glomerular Filtration Rate] <30, calculated from serum creatinine by the\n             Cockcroft-Gault formula).\n\n          -  Patients with a platelet count of <100.000 cells/mm\u00b3 or > 700.000 cells/mm\u00b3 or a\n             white blood cell< 3000 cells/mm\u00b3 within 7 days prior to index procedure or per\n             standard local practice.\n\n          -  Patients with a history of bleeding diathesis or coagulopathy or patients in whom\n             anti-platelet and/or anticoagulant therapy is contraindicated, or who will refuse\n             transfusion.\n\n          -  Patients who have received any organ transplant or are on a waiting list for any\n             organ transplant.\n\n          -  Patients with known other medical illness or known history of substance abuse that\n             may cause non-compliance with the protocol, confound the data interpretation or is\n             associated with a life expectancy of less than one year.\n\n          -  Patients with known hypersensitivity or contraindication to aspirin,\n             heparin/bivalirudin, clopidogrel/ticlopidine, nitinol, stainless steel alloy, and/or\n             contrast sensitivity that cannot be adequately pre-medicated.\n\n          -  Patients with a history of a stroke or transient ischemic attack (TIA) within the\n             prior 6 months.\n\n          -  Patients with an active peptic ulcer or history of upper gastrointestinal (GI)\n             bleeding within the prior 6 months.\n\n          -  Patients presenting with cardiogenic shock.\n\n          -  Patients with documented friable or mobile atherosclerotic plaque in the aortic arch.\n\n          -  Patients with contraindication to cerebral MRI.\n\n          -  Patients with any other cardiovascular procedure prior to TAVR\n\n          -  Patients with severe aortic arch atheroma visible on CT scan"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients indicated for TAVR procedure"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073864", 
            "org_study_id": "Yale Neuro TAVR"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 25, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Alexandra Lansky, Md."
                }, 
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }, 
                    "name": "Yale New Haven Hospital"
                }, 
                "investigator": {
                    "last_name": "Alexandra Lansky, Md.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Katzen Barry"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33176"
                    }, 
                    "name": "Baptist Hospital"
                }, 
                "investigator": {
                    "last_name": "Barry Katzen", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Moses Jeff, mD."
                }, 
                "facility": {
                    "address": {
                        "city": "Fort Lee", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07024"
                    }, 
                    "name": "Columbia University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Moses Jeff, Md.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "George Dangas, Md."
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Mount Sinai Hospital"
                }, 
                "investigator": {
                    "last_name": "George Dangas, Md.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Neurological Complications of Contemporary Unprotected TAVR (Yale Neuro TAVR)", 
        "overall_contact": {
            "email": "alexandra.lansky@yale.edu", 
            "last_name": "Alexandra Lansky, Md.", 
            "phone": "203-737-2142"
        }, 
        "overall_official": {
            "affiliation": "Yale Cardiovascular Clinical Research", 
            "last_name": "Alexandra Lansky, Md.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of new diffusion-weighted  MRI lesions", 
            "measure": "Incidence of diffusion-weighted  MRI lesions following TAVR without cerebral embolic protection", 
            "safety_issue": "No", 
            "time_frame": "1 week post procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073864"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Keystone Heart", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Keystone Heart", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}